PremiumPre-EarningsRETA Earnings this Week: How Will it Perform? Reata Pharmaceuticals downgraded to Neutral from Buy at Citi Reata Pharmaceuticals downgraded to Equal Weight from Overweight at Barclays PremiumThe FlyReata Pharmaceuticals downgraded to Hold from Buy at Jefferies Reata Pharmaceuticals downgraded to Neutral from Buy at Guggenheim Reata Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald PremiumThe FlyBiotech Alert: Searches spiking for these stocks today 3 Best Stocks to Buy Now, 7/25/2023, According to Top Analysts Reata Pharmaceuticals price target raised to $145 from $110 at Cantor Fitzgerald 
